Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time
Posted
August 26, 2026
Views
1,991
Likes
22
Comments
8
Engagement
August 26, 2026
1,991
22
8
1.51%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:21Now PlayingThe Food and Drug Administration has approved a new medication for pancreatic cancer patients called daraxonrasib, a once-daily pill that blocks RAS proteins and has been shown to double patient survival time when compared to standard chemotherapy treatment.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
